Peptide Receptor Radionuclide Therapy (PRRT) in Neuroendocrine Tumors (NETs)

Session 2 of IASNM Radiant Flashpoints Educational Web-Series.
Speaker: David L. Bushnell, MD,
Professor of Radiology, Division of Nuclear Medicine,
University of Iowa Hospitals & Clinics
Chief, Diagnostic Imaging Services,
Iowa City VA Medical Center
Learning Objectives:
1. Discuss the current updates on targeted radiomoleclar therapy in the US.
2. Review the development of Peptide Receptor Radionuclide Therapy (PRRT).
3. Evaluate the current state of PRRT in Neuroendocrine Tumors (NETs) in the US and future direction/implications.

• Catégorie